NewsRx

Search our medical news database

Brigham & Women's Hospital, Boston

Acute sciatica sufferers get only short-term relief from intravenous steroids

Published in Physician Business Week, March 14th, 2006

Although intravenous (IV) steroid injection reduces pain in patients with severe acute sciatica caused by a herniated spinal disk, the improvement is small and lasts only a few days, according to a study in the February 15, 2006, issue of the journal Spine.

Led by Axel Finckh of Brigham and Women's Hospital, Boston, the researchers studied the benefits of IV "pulse" steroid therapy in 65 patients hospitalized for sciatica related to a herniated intravertebral disk. In this condition, a bulging disk in the spinal column places pressure on a spinal nerve root. The result is pain, weakness, and numbness anywhere along the course of the sciatic nerve, which runs down...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Physician Business Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook